Peter Whitesell, MD
Sleep Medicine · Washington, DCNPI 1063507515
Payments from drug & device makers
Across 33 payments — averaging $121.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$3K
- Jazz Pharmaceuticals Inc.$449
- Inspire Medical Systems, Inc.$217
- Actelion Pharmaceuticals US, Inc.$112
- Pfizer$29
- Boehringer Ingelheim$22
- plus $68 from 4 others
What the payments were for
- Food & beverage$71818%
- Education$1794%
- Other$3,10478%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 2 | $3,104 |
| Jazz Pharmaceuticals Inc. | 21 | $449 |
| Inspire Medical Systems, Inc. | 3 | $217 |
| Actelion Pharmaceuticals US, Inc. | 1 | $112 |
| Pfizer | 1 | $29 |
| Boehringer Ingelheim | 1 | $22 |
| AstraZeneca | 1 | $22 |
| Harmony Biosciences LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (8279) DreamStation Bipap Auto Core$2,081
- (8269) DreamStation Cpap$1,024
- Inspire$138
- UPTRAVI$112
- OPSUMIT$112
How this compares
Too few sleep medicine providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 13 | $10,825 |
| Varenicline Tartrate | 26 | $5,879 |
| Zolpidem Tartrate | 95 | $996 |
| Doxepin Hcl | 28 | $812 |
| Fluticasone Propionate | 44 | $810 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $461 |
| Quetiapine Fumarate | 14 | $421 |
| Trazodone Hcl | 27 | $323 |
| Acetazolamide | 12 | $209 |
| Gabapentin | 20 | $129 |
| Prednisone | 19 | $112 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Washington
- Joseph ParkerWashington$25K
- Kalpana Hari HallWashington$4K
- Zara MartirosyanWashington$3K
- Christine ZhangWashington$831
- Sona AloyanWashington$250
- Frederick JacobsenWashington$40
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.